Li, Zhenyu
- Texas A&M Health Science Center · Pharmacology (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #12,634
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Pharmacology
NIH Funding · FY2022
Linked Award Amount
$808.2K
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#12,634
By linked amount among FY2022 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Li, Zhenyu as a PI. Multi-PI records show the full award amount for context.
- 7R01HL142640-04R01Contact PIInflammasome Activation Triggers Systemic Coagulation in SepsisTexas A&M Health Science Center · Pharmacology (NIH department code)$429.5Kaward amount
- 5R01GM132443-05R01Contact PIA novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophagesTexas A&M Health Science Center · Pharmacology (NIH department code)$378.8Kaward amount
Award organization
Organizations that administered FY2022 awards listing Li, Zhenyu as a PI.
FY2022 award administered by Texas A&M Health Science Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardTexas A&M Health Science Center
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #2117
- 2015Entered Top 25% NationallyRanked #2117
- 2016R01 Grant Holder
- 2020$5M Cumulative Funding